Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

E-ISSN： 1873-4286|19|13|2474-2488

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.13, 2013-04, pp. : 2474-2488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor cell resistance to DNA topoisomerase II inhibitors: new developments

By Beck W.T. Morgan S.E. Mo Y-Y. Bhat U.G.

Drug Resistance Updates, Vol. 2, Iss. 6, 1999-12 ,pp. : 382-389

Academic Press

Access to resources Recommend Favorite

Developments of DNA-dependent Protein Kinase Inhibitors as Anticancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 884-895

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging DNA topoisomerase inhibitors as anticancer drugs

By Denny William A

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 105-133

Informa Healthcare

Access to resources Recommend Favorite

A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons

By Capranico G. Binaschi M. Borgnetto M.E. Zunino F. Palumbo M.

Trends in Pharmacological Sciences, Vol. 18, Iss. 9, 1997-10 ,pp. : 323-329

Elsevier

Access to resources Recommend Favorite